PEREGRINE CAPITAL MANAGEMENT LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 180 filers reported holding TRANSMEDICS GROUP INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
PEREGRINE CAPITAL MANAGEMENT LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$4,697,550
-49.3%
85,800
-22.3%
0.14%
-44.4%
Q2 2023$9,270,300
+8.7%
110,387
-2.0%
0.25%
+2.4%
Q1 2023$8,530,682
+102370.7%
112,646
-16.5%
0.25%
-5.7%
Q4 2022$8,325
-99.9%
134,888
-2.9%
0.26%
+38.8%
Q3 2022$5,800,000138,9620.19%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2022
NameSharesValueWeighting ↓
Roubaix Capital, LLC 264,438$5,027,0004.84%
Abrams Capital Management 3,499,859$66,532,0002.07%
Sandhill Capital Partners LLC 736,175$13,995,0001.55%
EMERALD ADVISERS, LLC 451,542$8,584,0000.36%
RTW INVESTMENTS, LP 503,266$9,567,0000.36%
EMERALD MUTUAL FUND ADVISERS TRUST 429,868$8,172,0000.33%
NEXT CENTURY GROWTH INVESTORS LLC 107,045$2,034,0000.26%
ELEMENT CAPITAL MANAGEMENT LLC 63,175$1,201,0000.26%
HAMILTON LANE ADVISORS LLC 19,364$368,0000.16%
Harbour Capital Advisors, LLC 20,900$397,0000.15%
View complete list of TRANSMEDICS GROUP INC shareholders